Abstract
SENSOPAD revolutionizes women's health by addressing the challenges of Endometriosis (ED), often underdiagnosed due to its asymptomatic nature. Early detection improves health outcomes and reduces costs. SENSOPAD introduces two innovative ED sensing systems: SensoPad, embedded in sanitary pads, and SensoMFgFET, a portable Point-of-Care (POC) device. SensoPad features three Biological Processing Units (BPUs) for continuous monitoring, integrating electrochemical sensors, RFID, fuel cells, and electrochromic technology. SensoMFgFET captures specific DNA SNPs from menstrual fluid, enhancing early ED detection. A mobile app and AI-powered cloud platform support real-time analysis, bridging at-home monitoring with clinical precision. SENSOPAD aims to cut ED diagnosis time from years to days, enabling early treatment, optimizing fertility care, and transforming women's healthcare with accessible, accurate, and proactive solutions.
Unibo scientific coordinator
Prof. Giovanni Valenti - UNIBO Principal investigator
Partnership
Ethnicon Metsovion Polytechnion (Greece) – Project Coordinator
Copenhagen Business School (Denmark)
Universidade Da Coruna (Spain)
White Research Srl (Belgium)
Biog3d Monoprosopi Ike (Greece)
Signalgenerix Limited (Cyprus)
Graphenea Semiconductor SL (Spain)
Universidade De Coimbra (Portugal)
Innovation In Research & Engineering Solutions (Belgium)
International Iberian Nanotechnology Laboratory (Portugal)
Gals Bio Ltd (Israel)